Solaris Resources (CVE:SLS) Shares Down 2.7% – Here’s What Happened

Solaris Resources Inc. (CVE:SLS)’s stock price fell 2.7% during trading on Monday . The stock traded as low as C$5.95 and last traded at C$6.15. 53,313 shares traded hands during trading, a decline of 60% from the average session volume of 132,199 shares. The stock had previously closed at C$6.32.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. HC Wainwright raised Solaris Resources to a “strong-buy” rating in a research report on Monday, August 12th. Maxim Group raised Solaris Resources to a “strong-buy” rating in a report on Wednesday, July 3rd.

Solaris Resources Stock Performance

The company has a 50 day moving average of C$6.15.

Solaris Resources (CVE:SLS) last released its quarterly earnings results on Thursday, August 8th. The company reported C($0.16) EPS for the quarter.

Solaris Resources Company Profile

SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.